Antioxidants - Therapeutic use
Research News and Information

Saturday, November 21, 2009

Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation.

2 Nov 2009 The goal of this study was to elucidate the mechanisms of 17beta-estradiol (E(2)) antioxidant and neuroprotective actions in stroke. The results reveal a novel extranuclear receptor-mediated antioxidant mechanism for E(2) during stroke, as well as a ... Read more...

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.

Nov 2009 OBJECTIVE: To investigate the incidence of and risk factors for cognitive impairment in a large, well-defined clinical trial cohort of patients with early Parkinson disease (PD). METHODS: The Mini-Mental State Examination (MMSE) was administered ... Read more...

Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease.

29 Sep 2009 This randomized, double-blind, parallel trial assessed the influence of pomegranate juice consumption on anterior and posterior carotid intima-media thickness (CIMT) progression rates in subjects at moderate risk for coronary heart disease. Subjects ... Read more...

Latest indexed articles for 'Antioxidants - Therapeutic use'

These are the very latest articles for this heading:

• Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. 2 Nov 2009
• Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Nov 2009
• Quality of life in children with CMT type 1A. 29 Sep 2009
• Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. 29 Sep 2009
• Antioxidant therapy in the management of acute, chronic and post-ERCP pancreatitis: a systematic review. 26 Sep 2009
• Restoring erectile function by antioxidant therapy in diabetic rats. 15 Sep 2009
• A 52-year-old woman with disabling peripheral neuropathy: review of diabetic polyneuropathy. 6 Sep 2009
• alpha-Luminol prevents decreases in glutamate, glutathione, and glutamine synthetase in the retinas of glaucomatous DBA/2J mice. 30 Aug 2009
• Natural antioxidants: therapeutic prospects for cancer and neurological diseases. 30 Aug 2009
• Chronic pancreatitis. 30 Aug 2009
• Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain. 30 Aug 2009
• Topical polyphenolic antioxidants reduce the adverse effects of intense pulsed light therapy. 30 Aug 2009
• Enhancement of amlodipine cardioprotection by quercetin in ischaemia/reperfusion injury in rats. 30 Aug 2009
• Diabetic neuropathy: therapies on the horizon. 30 Aug 2009
• Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease. 30 Aug 2009
• Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. 30 Aug 2009
• Should we be considering selenium in glaucoma? 30 Aug 2009
• New drugs for exacerbations of chronic obstructive pulmonary disease. 27 Aug 2009
• [Prevention of restenosis and of cardiac events after coronary angioplasty in diabetics] 24 Aug 2009
• Effects of age, dietary, and behavioral enrichment on brain mitochondria in a canine model of human aging. 20 Aug 2009

See a longer list of these articles.

Technical information about 'Antioxidants'

Definition: Naturally occurring or synthetic substances that inhibit or retard the oxidation of a substance to which it is added. They counteract the harmful and damaging effects of oxidation in animal tissues.

Registry Number: 0

Descriptor UI: D000975

Alternative terms: Antioxidants;

Related Mesh Headings: Pharmaceutic Aids; Oxidative Stress;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; chemical synthesis; classification; diagnostic use; economics; history; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; chemistry; contraindications; physiology;

Tree Number: D27.505.519.217; D27.505.696.706.125; D27.720.799.047;